KidneyIntelX
For Payors
Reducing Costs, Improving Outcomes
Renalytix is committed to helping payors of all sizes reduce costs while improving the quality of care in patients’ lives. Our KidneyIntelX test is designed to help healthcare providers make actionable clinical management decisions, while reducing costly care and providing better outcomes for patients in need.
Value-Based Approach Informs Better Care
KidneyIntelX is designed to improve identification and clinical management of patients with Type 2 diabetes with fast-progressing kidney disease to reduce the estimated $114 billion annual cost of chronic and end-stage kidney disease to the United States healthcare system.
KidneyIntelX uses machine learning algorithms to assess a combination of predictive blood-based biomarkers and clinical data from a patient’s electronic health record to provide a KidneyIntelX Risk Score. This Risk Score is used to determine which patients with CKD are at low, intermediate, or high risk of rapid kidney function decline within 5 years.
Making an Impact on a Public Health Crisis
850 Million
estimated people with chronic kidney disease worldwide, with
37 Million
in the United States
60 million+
adults in the United States will be diagnosed with diabetes by 2060
$1.3 billion
can be saved over 5 years per 100,000 patients with diabetic kidney disease when tested with KidneyIntelX
Explore Resources for Payors
KidneyIntelX resources include clinical validation and utility data, health economic data, posters and publications.
Dedicated CPT® Code
The American Medical Association (AMA) has granted a CPT® Proprietary Laboratory Analyses Code for KidneyIntelX. The code, 0105U, has been approved and published by the AMA CPT Editorial Panel, and is effective as of October 1, 2019.
Renalytix Contracted Health Plans
September 2021
Plan Name
America’s Choice
BlueCross BlueShield of Illinois
CDPHP
Crescent Health PPO
Encore
Fortified
Galaxy Health
Healthfirst
Meridian
Multiplan
NovaNet
PRIME Health
The Alliance
Three Rivers
USA Managed Care
UWMA
Wellmark BCBS IA
Wellmark BCBS SD
Zelis
Location
Nevada
Illinois
Albany, NY
North Carolina, Georgia
Indiana
Arizona
Texas
New York City
Missouri
New York
Georgia
Tennessee
Wisconsin
Nevada
Texas
Ohio
Iowa
South Dakota
Georgia
State Medicaid Approvals:
Alabama
Arizona
Colorado
Georgia
Idaho
Illinois
Indiana
Kansas
Louisiana
Maine
Michigan
Minnesota
Montana
Nebraska
New Mexico
New York
North Carolina
Ohio
Oregon
Rhode Island
South Carolina
Utah
Vermont
Washington
Wisconsin
Wyoming
Renalytix Labs Overview
Our CLIA-certified diagnostic labs are committed to supporting clients through unparalleled quality and service. We have locations in Salt Lake City and New York City.
New York Lab
Renalytix’s New York state-of-the-art reference laboratory is situated in the New York Genome Center in Lower Manhattan.
101 6th Avenue, 3rd FL
New York, NY 10013
Salt Lake City Lab
Renalytix’s Utah state-of-the-art reference laboratory is located on the University of Utah Research Park campus.
421 Wakara Way, Suite 309,
Salt Lake City, UT 84108
Accreditations, Credentials and ISO Certificates
Access Renalytix’s licensing, accreditations and required state certifications.
Contact Us
If you are a payer or insurance provider, please contact our Market Access team to learn more about our KidneyIntelX test:
Shelley Glick
VP, Market Access
512-337-5559
sglick@renalytix.com